Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075566 | SCV001241193 | uncertain significance | Retinal dystrophy | 2019-01-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001862620 | SCV002130292 | likely pathogenic | not provided | 2023-09-21 | criteria provided, single submitter | clinical testing | This variant has been observed in individual(s) with clinical features of Stargardt disease (PMID: 25082829, 32307445). This variant is present in population databases (rs765263670, gnomAD 0.01%). This sequence change falls in intron 17 of the ABCA4 gene. It does not directly change the encoded amino acid sequence of the ABCA4 protein. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Studies have shown that this variant is associated with altered splicing resulting in multiple RNA products (PMID: 32307445). ClinVar contains an entry for this variant (Variation ID: 867061). |
Institute of Human Genetics, |
RCV001075566 | SCV005069162 | uncertain significance | Retinal dystrophy | 2015-01-01 | criteria provided, single submitter | clinical testing |